<?xml version="1.0" encoding="UTF-8"?>
<p id="p0295">Although it is not the main aim of this work, it is worthy to underline in this context that also for NPs the development of a new treatment, medicine, or any employment in food industry requires assessments of compounds safety, which is an important issue to be addressed in drug development and the cause of drug candidate attrition in the biopharmaceutical industry. Decision of any employment can only be made if both benefits and risks are addressed. The aim of safety tests, indeed, is to improve risk-benefit assessment at all stages of drug development (
 <xref rid="bib70" ref-type="bibr">Roberts, 2018</xref>). Internationally accepted guidelines were developed to monitor drugs, foods and also environmental contaminants for adverse reactions and toxicity and to ensure their safety.
</p>
